Antibody

Brazilian SARS-CoV-2 P.1 differentiation exhibits resistance to antibody neutralization

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 difference

Pfizer SARS-CoV-2 vaccine effective from day 11 after 1d vaccine

Research shows a causal relationship between neonatal antibody production and maternal microbiota

Microbes may predict lethal outcomes in COVID-19 infected patients

less neutralization, but still waterproof

A study shows antibody responses lasting 10 months after SARS-CoV-2 infection

Modern SARS-CoV-2 vaccine uses reconstituted spike protein with PIKA adjuvant

An immune response to SARS-CoV-2 may be limited by a set of genes

SARS-CoV-2 D614G mutation associated with lower antibody binding